[
    {
        "question": "What is the objective of the guideline provided by the American Society for Reproductive Medicine regarding oocyte cryopreservation?",
        "answer": "The objective is to provide evidence-based recommendations to practicing physicians and others regarding the efficacy of oocyte cryopreservation (OC) for donor oocyte in vitro fertilization and planned OC.",
        "is_verified": 1
    },
    {
        "question": "What methods were used to develop the evidence-based recommendations for oocyte cryopreservation?",
        "answer": "The American Society for Reproductive Medicine conducted a literature search that included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 1986 to 2018. A task force of experts used the available evidence to develop the recommendations through consensus.",
        "is_verified": 1
    },
    {
        "question": "What main outcomes were measured in the studies related to oocyte cryopreservation?",
        "answer": "The main outcomes of interest included live birth rate, clinical pregnancy rate, obstetrical and neonatal outcomes, and factors predicting reproductive outcomes.",
        "is_verified": 1
    },
    {
        "question": "What were the findings regarding live birth rates after planned oocyte cryopreservation?",
        "answer": "The conclusion indicated that there is insufficient evidence to predict live birth rates after planned OC. However, ongoing and live birth rates appear to be improved for women who undergo planned OC at a younger age compared to older age.",
        "is_verified": 1
    },
    {
        "question": "What recommendations were made regarding neonatal outcomes in relation to oocyte cryopreservation?",
        "answer": "Recommendations were developed regarding neonatal outcomes after using fresh versus cryopreserved oocytes in cases of autologous or donor oocytes.",
        "is_verified": 1
    },
    {
        "question": "What are the differences in pregnancy rates between cryopreserved and fresh donor oocytes?",
        "answer": "There are differences in per transfer pregnancy rates with cryopreserved versus fresh donor oocytes, but there is insufficient evidence that the live birth rate is the same with vitrified versus fresh donor oocytes.",
        "is_verified": 1
    },
    {
        "question": "What are the neonatal outcomes associated with cryopreserved oocytes?",
        "answer": "Neonatal outcomes appear similar with cryopreserved oocytes compared with fresh oocytes.",
        "is_verified": 1
    },
    {
        "question": "What is oocyte cryopreservation and how has it evolved?",
        "answer": "Oocyte cryopreservation (OC) has existed for decades, but recent technological improvements have led to its widespread clinical use. The first human pregnancy from a previously cryopreserved oocyte was reported in 1986. Rapid cooling, known as vitrification, has become a standard protocol for OC, minimizing intracellular ice crystal formation and improving post-warming oocyte survival.",
        "is_verified": 1
    },
    {
        "question": "What did the American Society for Reproductive Medicine (ASRM) state about oocyte freezing in 2013?",
        "answer": "In 2013, the ASRM Practice Committee stated that oocyte freezing is not 'experimental' and allowed for its routine use in postmenarchal women facing gonadotoxic therapies. However, they did not recommend OC for the sole purpose of circumventing reproductive aging in healthy women due to limited data on safety, efficacy, ethics, emotional risks, and cost-effectiveness.",
        "is_verified": 1
    },
    {
        "question": "What are the indications for the use of oocyte cryopreservation?",
        "answer": "The use of oocyte cryopreservation has expanded for women facing gonadotoxic treatments, delaying childbearing, and for the purpose of oocyte donation.",
        "is_verified": 1
    },
    {
        "question": "What is the purpose of oocyte donation?",
        "answer": "The purpose of oocyte donation is to assist individuals or couples who are unable to conceive due to various medical reasons, such as diminished ovarian reserve or genetic disorders. Oocyte donation allows these individuals to achieve pregnancy through assisted reproductive technologies.",
        "is_verified": 1
    },
    {
        "question": "What is the purpose of the guideline mentioned in the excerpt?",
        "answer": "The purpose of the guideline is to provide a systematic review of success rates (live birth rates and clinical pregnancy rates), factors that may impact success rates (such as age and ovarian reserve testing), and obstetrical and neonatal outcomes in scenarios of planned oocyte cryopreservation (OC) and cryopreserved donor oocytes.",
        "is_verified": 1
    },
    {
        "question": "What factors may impact success rates in planned oocyte cryopreservation?",
        "answer": "Factors that may impact success rates include age and ovarian reserve testing.",
        "is_verified": 1
    },
    {
        "question": "What does the document review regarding in vitro fertilization (IVF)?",
        "answer": "The document reviews outcomes after in vitro fertilization (IVF) with cryopreserved oocytes from infertile women, particularly in scenarios where women wish to preserve supernumerary oocytes for future use or face unplanned unavailability of spermatozoa at the time of oocyte retrieval.",
        "is_verified": 1
    },
    {
        "question": "What limitations exist in the literature related to oocyte cryopreservation (OC)?",
        "answer": "Limitations include a lack of untreated or control groups in studies, changes in technology over time that affect the extrapolation of success rates, and variations in protocols for embryo transfer that complicate the study of blastulation rates and embryo quality.",
        "is_verified": 1
    },
    {
        "question": "What types of outcomes do many studies report on regarding oocyte cryopreservation?",
        "answer": "Many studies present data on intermediate outcomes such as survival post-warming, fertilization, or blastulation rates.",
        "is_verified": 1
    },
    {
        "question": "What is the significance of cryopreserved oocytes in fertility preservation?",
        "answer": "The use of cryopreserved oocytes is increasing among women seeking to preserve their fertility, as it allows them to attempt pregnancy later in life. However, only a small proportion of women with cryopreserved oocytes have returned to use them for pregnancy attempts.",
        "is_verified": 1
    },
    {
        "question": "What are the expected live birth rates for women who undergo planned oocyte cryopreservation (OC)?",
        "answer": "As of the date of publication, there are no randomized controlled trials that definitively answer whether lifetime autologous live birth rates differ between women who have cryopreserved oocytes and those who have not. The guideline includes studies attempting to address this question, but the quality of evidence varies.",
        "is_verified": 1
    },
    {
        "question": "What types of studies are included in the guidelines regarding neonatal outcomes after using cryopreserved oocytes?",
        "answer": "The guidelines include data from retrospective case series and mention one intermediate-quality cohort study and two low-quality observational studies that attempt to address the questions regarding live birth rates and outcomes related to cryopreserved oocytes.",
        "is_verified": 1
    },
    {
        "question": "What challenges exist in generalizing findings from studies on cryopreserved oocytes?",
        "answer": "Published studies generally come from high-volume centers, raising uncertainty about whether the findings can be generalized to lower-volume centers, which may have different patient populations and outcomes.",
        "is_verified": 1
    },
    {
        "question": "What was the sample size of the study conducted by Doyle et al. regarding warmed, vitrified oocytes?",
        "answer": "Doyle et al. identified all autologous IVF embryo transfer cycles of warmed, vitrified oocytes performed at their center between 2009 and January 2015, with a sample size of 128 cycles.",
        "is_verified": 1
    },
    {
        "question": "What were the outcomes of IVF cycles using vitrified/warmed oocytes compared to fresh oocytes?",
        "answer": "The IVF outcomes from vitrified/warmed oocytes were compared with those from fresh autologous intracytoplasmic sperm injection (ICSI) cycles. The mean age at retrieval was similar between the two groups (34.9 years for vitrified vs. 35.5 years for fresh). The number of MII oocytes inseminated was lower in the vitrified oocyte group (8.0 vs. 10.1), but the fertilization rate with ICSI was comparable (69.5% vs. 71.7%). Fewer cycles resulted in blastocyst-stage embryo transfer for vitrified oocytes (50.9% vs. 66.1%). Despite lower blastocyst progression rates, there was no difference in cycles without embryo transfer (4.2% vs. 4.7%). Adjusted implantation rates and clinical pregnancy rates were significantly greater among embryos derived from vitrified oocytes, but pregnancy loss per clinical pregnancy was also greater among vitrified oocytes. Ongoing pregnancy rates per transfer were equivalent between autologous cryopreserved and fresh oocytes (38.6% vs. 36%). There was no difference in live birth rates among women who underwent planned ovarian cryopreservation (OC) compared to those who were infertile and cryopreserved for other reasons.",
        "is_verified": 1
    },
    {
        "question": "What was the live birth rate reported by Nagy et al. after autologous oocyte vitrification and warming?",
        "answer": "The live birth rate reported by Nagy et al. after autologous oocyte vitrification and warming was 17.4%.",
        "is_verified": 1
    },
    {
        "question": "What was the mean age of women who underwent planned oocyte cryopreservation (OC) in the study by Nagy et al.?",
        "answer": "The mean age of women who underwent planned oocyte cryopreservation (OC) in the study was 33.9 years, with a standard deviation of 3.9 years.",
        "is_verified": 1
    },
    {
        "question": "What is the significance of the limited evidence mentioned in the excerpt regarding live birth rates?",
        "answer": "The excerpt indicates that there is extremely limited evidence to predict the likelihood of live birth in women who undergo planned oocyte cryopreservation, highlighting a gap in research and understanding in this area of fertility treatment.",
        "is_verified": 1
    },
    {
        "question": "What are the live birth rates for infertile women using autologous cryopreserved oocytes?",
        "answer": "The excerpt discusses 11 intermediate-quality studies on live birth rates among infertile women using autologous cryopreserved oocytes for nonelective indications. It mentions that in a study by Rienzi et al., 54 out of 124 patients (43.2%) conceived with a fresh embryo transfer. Among the vitriﬁcation group, the clinical pregnancy rate per embryo transfer was 38.5% and the ongoing pregnancy rate per embryo transfer was 30.8%.",
        "is_verified": 1
    },
    {
        "question": "What does the study by Rienzi et al. reveal about the comparison between fresh and vitriﬁed oocytes?",
        "answer": "The study by Rienzi et al. found no significant difference between groups of sibling oocytes in terms of fertilization rate, embryo development, or percentage of excellent-quality embryos when comparing fresh and vitriﬁed groups. However, it noted that embryos were not cultured past day 2, which limits the interpretation of pregnancy outcomes between fresh and vitriﬁed oocytes due to the study design.",
        "is_verified": 1
    },
    {
        "question": "What is the significance of the cohort study mentioned in the excerpt regarding IVF with fresh versus cryopreserved oocytes?",
        "answer": "The cohort study reported similar ongoing clinical pregnancy per transfer rates in women undergoing IVF with fresh compared to previously cryopreserved oocytes, indicating that both methods may yield comparable outcomes in terms of ongoing pregnancies.",
        "is_verified": 1
    },
    {
        "question": "What were the pregnancy rates per transfer cycle for autologous cryopreserved and fresh oocytes?",
        "answer": "The pregnancy rates per transfer cycle were 38.6% for autologous cryopreserved oocytes and 36% for fresh oocytes, which were not significantly different (P>.05).",
        "is_verified": 1
    },
    {
        "question": "What were the outcomes of the study by Almodin et al. regarding live birth rates after using cryopreserved oocytes?",
        "answer": "In the first vitrified warming cycle among 100 patients using cryopreserved oocytes, 32 (32%) had a live birth. In a second vitrified warming cycle among 20 unsuccessful patients, 6 (20%) had a term live birth.",
        "is_verified": 1
    },
    {
        "question": "What did Crawford et al. find regarding the rates of cancellation, implantation, pregnancy, miscarriage, or live birth between autologous fresh and cryopreserved oocyte cycles?",
        "answer": "Crawford et al. found no evidence of differences in rates of cancellation, implantation, pregnancy, miscarriage, or live birth rate between autologous fresh and cryopreserved oocyte cycles. The live birth rates were 37.4% for fresh oocytes and 30.6% for cryopreserved oocytes, with an absolute risk reduction of 1.05 and a 95% confidence interval of [0.86–1.30].",
        "is_verified": 1
    },
    {
        "question": "What factors were associated with live birth for autologous cryopreserved oocyte cycles?",
        "answer": "The availability of embryos was the only factor associated with live birth for autologous cryopreserved oocyte cycles.",
        "is_verified": 1
    },
    {
        "question": "What was the age range of couples undergoing multiple cycles of ovarian stimulation in the study?",
        "answer": "The age range of couples was 29 to 42.3 years, with a mean age of 36.6 years.",
        "is_verified": 1
    },
    {
        "question": "What were the clinical outcomes compared between fresh and cryopreserved oocytes?",
        "answer": "Clinical outcomes were comparable between fresh and cryopreserved oocytes, with no differences in fertilization rate, clinical pregnancies per embryo transfer, and implantation rate.",
        "is_verified": 1
    },
    {
        "question": "What is ovarian hyperstimulation syndrome and how was it assessed in the studies?",
        "answer": "Ovarian hyperstimulation syndrome is a condition that can occur in women undergoing fertility treatments. Two cohort studies assessed outcomes after oocyte vitrification in women at risk for this syndrome, analyzing outcomes of patients who were coasted versus those who underwent oocyte vitrification followed by warming and ICSI.",
        "is_verified": 1
    },
    {
        "question": "What was the implantation rate for vitriﬁed oocytes compared to coasted groups?",
        "answer": "The implantation rate was higher in the vitriﬁed oocyte group compared to the coasted group.",
        "is_verified": 1
    },
    {
        "question": "What was the clinical pregnancy rate reported in the study?",
        "answer": "The clinical pregnancy rate was 50% in one group compared to 29.5% in another group (P<.005).",
        "is_verified": 1
    },
    {
        "question": "What condition did the second study focus on that required delayed embryo transfer?",
        "answer": "The second study focused on ovarian hyperstimulation syndrome risk, which led to the need for delayed embryo transfer.",
        "is_verified": 1
    },
    {
        "question": "How did the fertilization rate compare between the oocyte vitrification group and the embryo vitrification group?",
        "answer": "The fertilization rate and the number of 'useful embryos' were significantly lower in the oocyte vitrification group compared to the embryo vitrification group.",
        "is_verified": 1
    },
    {
        "question": "What were the survival and fertilization rates for vitriﬁcation compared to slow cooling?",
        "answer": "Overall survival and fertilization rates were higher with vitriﬁcation (85% and 79%) than with slow cooling (65% and 74%; P<.001).",
        "is_verified": 1
    },
    {
        "question": "What is the implantation rate for oocytes vitriﬁed at different ages?",
        "answer": "The implantation rate was 13.2% per oocyte vitriﬁed at 30 years compared with 8.6% for oocytes vitriﬁed at 40 years.",
        "is_verified": 1
    },
    {
        "question": "What did Potdar et al. analyze regarding fertility outcomes?",
        "answer": "Potdar et al. analyzed 21 articles comparing fertility outcomes using vitriﬁed and fresh oocytes with a mix of donor and autologous oocyte sources, finding no significant difference in fertilization, cleavage, and clinical pregnancy rates between vitriﬁed and fresh oocytes.",
        "is_verified": 1
    },
    {
        "question": "What was the ongoing pregnancy rate for warmed oocytes in the vitriﬁed group?",
        "answer": "The ongoing pregnancy rate (defined as pregnancy progressing >20 weeks) per warmed oocyte was lower in the vitriﬁed group, with 199 out of 4358 (4.6%).",
        "is_verified": 1
    },
    {
        "question": "What is the impact of age on live birth rates among women undergoing oocyte cryopreservation?",
        "answer": "Age is a critical factor predicting live birth rates among women with infertility undergoing in vitro fertilization. Specifically, the clinical pregnancy rate for patients under 38 years was found to be 60.2%, compared to 43.9% for patients aged 38 years and older. Additionally, oocyte efficiency decreases with increasing age, with a reported efficiency of 7.4% for women under 30 years.",
        "is_verified": 1
    },
    {
        "question": "What are the recommendations regarding oocyte cryopreservation (OC) for women facing unexpected circumstances during retrieval?",
        "answer": "It is recommended that oocyte cryopreservation (OC) be offered as an option for women in situations where there is an unanticipated lack of sperm on the day of retrieval, or for those who wish to limit the number of fertilized embryos. The strength of evidence for this recommendation is classified as B, with a moderate strength of recommendation.",
        "is_verified": 1
    },
    {
        "question": "What does the sensitivity analysis reveal about ongoing pregnancy rates in relation to oocyte use?",
        "answer": "The sensitivity analysis indicates that the reduction in ongoing pregnancy rates was observed in nonrandomized control trials (non-RCTs) but not in randomized controlled trials (RCTs). This suggests variability in outcomes based on the type of study design used.",
        "is_verified": 1
    },
    {
        "question": "What limitations exist in assessing live birth rates per warmed oocyte?",
        "answer": "The assessment of live birth rates per warmed oocyte is limited due to differences between studies in how ongoing pregnancy and live birth rates are reported, leading to challenges in drawing definitive conclusions.",
        "is_verified": 1
    },
    {
        "question": "What is the impact of age on live birth rates for women undergoing planned oocyte cryopreservation (OC)?",
        "answer": "Live birth rates appear to be improved for women who undergo planned oocyte cryopreservation at a younger age compared to older women. Specifically, women under 35 years had a live birth rate of 23.8%, while those 35 years and older had a rate of 12.0%.",
        "is_verified": 1
    },
    {
        "question": "What recommendations are made regarding the timing of oocyte cryopreservation?",
        "answer": "It is recommended to counsel women that live birth rates per embryo transfer are improved when oocyte cryopreservation is performed in younger women as compared to older women. However, there are insufficient data to advise on the optimal age to undergo planned oocyte cryopreservation.",
        "is_verified": 1
    },
    {
        "question": "What factors are considered in evaluating outcomes of oocyte cryopreservation?",
        "answer": "Factors such as baseline demographic characteristics or comorbidities at the time of freezing, including body mass index (BMI), smoking, and ethnicity, are considered in evaluating outcomes. However, there are no randomized trials that specifically evaluate these factors independent of age.",
        "is_verified": 1
    },
    {
        "question": "What is the evidence regarding demographic characteristics or comorbidities affecting outcomes of planned oocyte cryopreservation?",
        "answer": "There is insufficient evidence to recommend that demographic characteristics or comorbidities, independent of age, affect the outcome of planned oocyte cryopreservation (OC).",
        "is_verified": 1
    },
    {
        "question": "Does ovarian reserve testing predict live birth rates after oocyte freezing independent of age?",
        "answer": "There are no randomized trials or observational studies that evaluate the impact of ovarian reserve on live birth rate after oocyte cryopreservation, independent of age. Ovarian reserve testing predicts the number of oocytes produced per cycle in the IVF literature.",
        "is_verified": 1
    },
    {
        "question": "What is the recommendation regarding ovarian reserve testing to predict live birth rates after planned oocyte cryopreservation?",
        "answer": "There is insufficient evidence to recommend ovarian reserve testing to predict live birth rates after planned oocyte cryopreservation for any indication, independent of age.",
        "is_verified": 1
    },
    {
        "question": "How many mature oocytes should be cryopreserved to achieve a reasonable chance of live birth?",
        "answer": "To maximize the likelihood of future pregnancies with warmed oocytes, patients and physicians need guidance regarding the optimal number of oocytes to cryopreserve. However, there are no randomized controlled trials to address this question, and included studies are of varying quality.",
        "is_verified": 1
    },
    {
        "question": "What did Doyle et al. analyze regarding live birth efficiency per warmed oocyte?",
        "answer": "Doyle et al. analyzed 128 autologous IVF treatment cycles, in which 1283 vitrified oocytes were warmed, and found that oocyte efficiency decreased with age group.",
        "is_verified": 1
    },
    {
        "question": "What is the estimated number of mature oocytes needed for women aged 30-34 to achieve a 70% chance of one live birth?",
        "answer": "Women aged 30-34 years would need to cryopreserve 14 mature oocytes to achieve a 70% chance of one live birth.",
        "is_verified": 1
    },
    {
        "question": "How does the efficiency of warmed oocytes compare between women under 35 and women 35 years and older?",
        "answer": "Among women under 35 years, each warmed oocyte produced a 2.6% chance of live birth, compared to 1.3% among women 35 years and older.",
        "is_verified": 1
    },
    {
        "question": "What is the calculated number of oocytes needed for a live birth among women under 35 years?",
        "answer": "Among women under 35 years, 38.8 oocytes are needed for a live birth.",
        "is_verified": 1
    },
    {
        "question": "What is the calculated number of oocytes needed for a live birth among women 35 years and older?",
        "answer": "Among women 35 years and older, 77 oocytes are needed for a live birth.",
        "is_verified": 1
    },
    {
        "question": "What does the study suggest about oocyte efficiency and age?",
        "answer": "The study suggests that oocyte efficiency decreases with increasing age.",
        "is_verified": 1
    },
    {
        "question": "What is the recommendation regarding counseling women on the number of oocytes necessary for a live birth after planned oocyte cryopreservation?",
        "answer": "There is insufficient evidence to counsel women of various ages on the absolute number of oocytes necessary to achieve a reasonable probability of a live birth after planned oocyte cryopreservation.",
        "is_verified": 1
    },
    {
        "question": "What were the neonatal outcomes reported for women who used cryopreserved oocytes?",
        "answer": "Five live births and 8 ongoing pregnancies were reported from a small cohort study involving 26 women who returned to use their cryopreserved oocytes. The mean live birth weight was reported as 3150 g, but the study provided limited obstetric and neonatal information.",
        "is_verified": 1
    },
    {
        "question": "What did the retrospective cohort study by Cobo et al. find regarding neonatal health outcomes?",
        "answer": "The study compared neonatal health outcomes between children born from vitriﬁed oocytes and those from fresh oocytes. No differences were found in rates of obstetric problems (including diabetes, pregnancy-induced hypertension, preterm birth, anemia, and cholestasis), gestational age at delivery, birth weight, Apgar scores, birth defects, admission to neonatal intensive care unit, perinatal mortality, and puerperal problems. Additionally, no differences in neonatal health outcomes were detected between the use of autologous and donor cryopreserved oocytes.",
        "is_verified": 1
    },
    {
        "question": "What were the findings regarding neonatal outcomes from cryopreserved oocytes compared to fresh oocytes?",
        "answer": "Four intermediate-quality retrospective cohort studies observed neonatal outcomes from previously cryopreserved oocytes. Anzola et al. reported that maternal characteristics, obstetric outcomes, and perinatal outcomes were similar in vitriﬁed/warmed oocyte/ICSI and fresh oocytes/ICSI groups. Chamayou et al. found no statistical difference in the risk of low birth weight, large for gestational age, birth defects, and cesarean section between the first 50 babies born after autologous oocyte vitriﬁcation/warming cycles and a control group of 364 children conceived by fresh oocytes with IVF. Siano et al. conducted a pilot study where neonatal health outcomes of pregnancies resulting in deliveries from vitriﬁed oocytes were compared with age-matched controls undergoing fresh oocyte IVF, showing no significant difference in obstetric, perinatal, and neonatal health outcomes between the two groups.",
        "is_verified": 1
    },
    {
        "question": "What percentage of live births from previously cryopreserved oocytes had congenital anomalies?",
        "answer": "A case series reported on 936 live births from previously cryopreserved oocytes, of which 1.3% (n=12) had congenital anomalies.",
        "is_verified": 1
    },
    {
        "question": "What limitations were noted in the studies regarding cryopreserved oocytes?",
        "answer": "Some major limitations noted in the studies include the inclusion of case and series reports, not all reported births being subjected to peer review, and the lack of complete neonatal health information for every reported pregnancy and birth.",
        "is_verified": 1
    },
    {
        "question": "What are the neonatal outcomes for oocytes previously cryopreserved for autologous use compared to fresh oocytes?",
        "answer": "Neonatal outcomes appear similar for oocytes previously cryopreserved for autologous use in infertile women compared with fresh oocytes, based on limited evidence from a small number of births.",
        "is_verified": 1
    },
    {
        "question": "What is the strength of evidence regarding neonatal outcomes for cryopreserved versus fresh oocytes?",
        "answer": "The strength of evidence is classified as C, and the strength of recommendation is weak.",
        "is_verified": 1
    },
    {
        "question": "Is there sufficient evidence to counsel patients about the long-term use of cryopreserved oocytes?",
        "answer": "There is insufficient evidence to counsel patients regarding the likelihood of the long-term use of oocytes cryopreserved for planned ovarian cryopreservation (OC).",
        "is_verified": 1
    },
    {
        "question": "What does the guideline say about clinical pregnancy rates and live birth rates for women using cryopreserved versus fresh donor oocytes?",
        "answer": "The guideline refers to one high-quality randomized controlled trial and several cohort studies but indicates that there are currently no randomized controlled trials addressing live birth rates using fresh versus cryopreserved donor oocytes.",
        "is_verified": 1
    },
    {
        "question": "What were the findings of the trial comparing ongoing pregnancy rates between fresh and cryopreserved donor oocytes?",
        "answer": "The trial found no statistically significant difference in ongoing pregnancy rates between fresh (43%) and cryopreserved (41%) donor oocytes (P>.05).",
        "is_verified": 1
    },
    {
        "question": "What were the findings regarding ongoing pregnancy rates comparing fresh vs. previously vitrified oocytes?",
        "answer": "Four cohort studies found no significant difference in ongoing pregnancy rates when comparing fresh versus previously vitrified oocytes. However, two studies noted that the average age of donors was lower in the vitrified group and that the mean number of oocytes collected in the vitrified group was significantly higher, which could have affected the results.",
        "is_verified": 1
    },
    {
        "question": "What was the ongoing pregnancy rate with warmed donor oocytes according to the meta-analysis?",
        "answer": "The meta-analysis calculated an ongoing pregnancy rate with warmed donor oocytes of 8%.",
        "is_verified": 1
    },
    {
        "question": "What were the clinical pregnancy rates per warmed oocyte for fresh and vitrified donor oocytes?",
        "answer": "The clinical pregnancy rates per warmed oocyte were 7.9% for fresh donor oocytes (512 out of 6511) and 6.4% for vitrified donor oocytes (330 out of 5140), with an odds ratio of 0.87 (95% CI 0.76–1.01), indicating no significant difference between the two groups.",
        "is_verified": 1
    },
    {
        "question": "What did the study assess regarding the effect of double vitrification on pregnancy rates?",
        "answer": "The study assessed the effect of double vitrification on pregnancy rates by comparing the transfer of cryopreserved embryos derived from vitrified oocytes versus fresh oocytes. The delivery rates were not significantly different for either day 3 frozen embryo transfers (33.2% for vitrified vs. 30.4% for fresh) or blastocyst transfers (31.5% for vitrified vs. 32.4% for fresh).",
        "is_verified": 1
    },
    {
        "question": "What were the outcomes of the prospective cohort study by Trokoudes et al. regarding live birth rates?",
        "answer": "The prospective cohort study by Trokoudes et al. matched each donor with one to two recipients of fresh oocytes and one recipient of previously cryopreserved oocytes. The outcomes were compared between recipients of fresh oocytes and those of vitrified oocytes, but specific results regarding live birth rates are not provided in the excerpt.",
        "is_verified": 1
    },
    {
        "question": "What are the advantages of using cryopreserved oocytes in fertility treatments?",
        "answer": "The advantages of using cryopreserved oocytes include the ability to control donor characteristics between recipients, as they can be matched, and the standardization of the mean number of oocytes received per recipient, which was reported as 6.0 versus 5.8 in the study. This standardization can help in assessing the outcomes of fertility treatments more accurately.",
        "is_verified": 1
    },
    {
        "question": "What were the live birth rates for fresh and cryopreserved oocytes according to the retrospective analysis?",
        "answer": "The live birth rates were 51.1% for fresh oocytes and 39.7% for cryopreserved oocytes per recipient cycle start, and 56.4% for fresh oocytes and 45.3% for cryopreserved oocytes per embryo transfer.",
        "is_verified": 1
    },
    {
        "question": "What was the cycle cancellation rate for cryopreserved oocytes in 2015 compared to 2013?",
        "answer": "The cycle cancellation rate for cryopreserved oocytes was 15% in 2015 compared to 8.5% in 2013.",
        "is_verified": 1
    },
    {
        "question": "What does the summary statement indicate about pregnancy rates between fresh and previously vitrified donor oocytes?",
        "answer": "The summary statement indicates that there is moderate evidence that pregnancy rates per transfer between fresh and previously vitrified donor oocytes are not significantly different.",
        "is_verified": 1
    },
    {
        "question": "What is the recommendation regarding the use of cryopreserved donor oocytes?",
        "answer": "The recommendation is to inform recipients that previously cryopreserved donor oocytes are a reasonable option compared with fresh donor oocytes, as there is good evidence that there are no significant differences in per transfer pregnancy rates.",
        "is_verified": 1
    },
    {
        "question": "What factors are associated with the survival of vitriﬁed oocytes according to the studies mentioned?",
        "answer": "The factors associated with the survival of vitriﬁed oocytes include donor age, storage duration, number of oocytes vitriﬁed/warmed, donor’s BMI, stimulation duration, total doses of gonadotropins, donor’s peak estradiol and progesterone levels on the day of human chorionic gonadotropin, and ovarian stimulation protocols.",
        "is_verified": 1
    },
    {
        "question": "What was the outcome of the studies regarding the predictive variables for pregnancy rates using vitriﬁed oocytes?",
        "answer": "The studies found that none of the evaluated variables were predictive of a higher pregnancy rate. The only statistically significant variables in regression models evaluating oocyte survival rates were donor age, number of oocytes vitriﬁed, and total human menopausal gonadotropin dose, but the differences accounted for using these variables were quite small (<1%).",
        "is_verified": 1
    },
    {
        "question": "What were the pregnancy rates per recipient using fresh versus cryopreserved donor oocytes?",
        "answer": "The pregnancy rate per recipient using fresh donor oocytes was 49.8% (n = 289 recipients) and using cryopreserved donor oocytes was 50.2% (n = 295 recipients). Other studies reported pregnancy rates of 60.9% for fresh and 59.0% for cryopreserved, and 60.0% for fresh and 61.8% for cryopreserved oocytes, respectively.",
        "is_verified": 1
    },
    {
        "question": "What is the significance of the live birth rate data presented in the excerpt?",
        "answer": "The excerpt presents live birth rate data comparing the use of fresh donor oocytes versus cryopreserved donor oocytes. It indicates that the live birth rate per recipient using fresh donor oocytes is 41.5% while using cryopreserved donor oocytes is 47.2%, with a P value indicating that the difference is not statistically significant (NS) for the study by Trokoudes et al. In contrast, the study by Kushnir et al. shows a live birth rate of 51.1% for fresh oocytes compared to 39.7% for cryopreserved oocytes, with a statistically significant P value (<.001), suggesting that fresh oocytes may lead to higher live birth rates in that study.",
        "is_verified": 1
    },
    {
        "question": "What does oocyte cryopreservation refer to in the context of reproductive medicine?",
        "answer": "Oocyte cryopreservation refers to the process of freezing and storing a woman's eggs (oocytes) for future use in assisted reproductive technologies such as in vitro fertilization (IVF). This technique allows women to preserve their fertility, particularly if they are facing medical treatments that may affect their reproductive capabilities or if they wish to delay childbearing for personal or professional reasons.",
        "is_verified": 1
    },
    {
        "question": "What factors have been examined in cohort studies regarding success rates in ovarian stimulation?",
        "answer": "Cohort studies have examined factors such as the type of stimulation protocol used for ovarian stimulation and the duration of oocyte storage, finding no significant differences in success rates. Additionally, the number of oocytes used has been associated with cumulative live birth rates, with a plateau reached at 40 oocytes.",
        "is_verified": 1
    },
    {
        "question": "What role does the uterine environment play in success rates of oocyte donation?",
        "answer": "The uterine environment and preparation of the endometrium may influence success rates. A cohort study reported higher implantation rates in recipient cycles using cryopreserved oocytes compared to autologous fresh transfer cycles.",
        "is_verified": 1
    },
    {
        "question": "What were the findings of the cohort study comparing fresh and cryopreserved oocytes?",
        "answer": "The study found a significant correlation in live birth rates using previously vitrified oocytes, with 60% of recipients having a live birth if the recipient of the fresh oocytes had a live birth, compared to only 18.2% if the recipient did not have a live birth on the fresh cycle.",
        "is_verified": 1
    },
    {
        "question": "Were there any differences in embryo morphology between the groups in the oocyte sharing program study?",
        "answer": "No statistically significant differences were observed in embryo morphology between the groups, although there was a wide range of donor ages.",
        "is_verified": 1
    },
    {
        "question": "What is the relationship between the number of donor oocytes warmed and the cumulative live birth rate?",
        "answer": "As the number of donor oocytes warmed increases, there is an associated increase in cumulative live birth rate.",
        "is_verified": 1
    },
    {
        "question": "What is the impact of using vitrified oocytes from donors with prior successful outcomes on live birth rates?",
        "answer": "Live birth rates may be greater from vitrified oocytes that derive from donors who had a prior successful outcome after a fresh cycle of oocyte donation.",
        "is_verified": 1
    },
    {
        "question": "Does the length of time oocytes have been cryopreserved affect oocyte survival or pregnancy rates?",
        "answer": "The length of time oocytes have been cryopreserved is not associated with differences in oocyte survival or pregnancy rates.",
        "is_verified": 1
    },
    {
        "question": "What are the concerns regarding obstetrical outcomes and health of offspring after using cryopreserved donor oocytes?",
        "answer": "Obstetrical outcomes and health of the offspring remain a concern after the implementation of new technologies in assisted reproduction, with limited studies addressing these questions in cryopreserved donor oocytes.",
        "is_verified": 1
    },
    {
        "question": "What did the retrospective cohort study examine regarding obstetrical and neonatal outcomes?",
        "answer": "The retrospective cohort study examined obstetrical and neonatal outcomes of singleton and multiple pregnancies conceived with the use of fresh and vitrified donor oocytes over a period of approximately 5 years.",
        "is_verified": 1
    },
    {
        "question": "What were the neonatal outcomes reported for pregnancies conceived with vitrified donor oocytes?",
        "answer": "The neonatal outcomes reported for pregnancies conceived with vitrified donor oocytes included a mortality rate of 0.2% (3 out of 1674 delivered neonates), one case of trigonocephaly, two cases of unilateral renal hypoplasias, one case of Kawasaki syndrome, and one case of West syndrome.",
        "is_verified": 1
    },
    {
        "question": "What is the significance of the increased risk of chorionic villus sampling or amniocentesis in singleton pregnancies conceived with vitrified donor oocytes?",
        "answer": "The increased risk of chorionic villus sampling or amniocentesis in singleton pregnancies conceived with vitrified donor oocytes (16.3% vs. 8.3% for fresh donor oocytes) suggests that there may be a lesser amount of experience with oocyte vitrification, which could lead to more invasive procedures being performed, although no abnormal results were found from these procedures.",
        "is_verified": 1
    },
    {
        "question": "What differences were observed in the sex ratio of neonates born from multiple pregnancies conceived with vitrified versus fresh donor oocytes?",
        "answer": "There were more female neonates born among multiple pregnancies conceived from vitrified donor oocytes (52.1%) compared to those conceived from fresh donor oocytes (42.2%).",
        "is_verified": 1
    },
    {
        "question": "What are the neonatal outcomes associated with cryopreserved vs. fresh donor oocytes?",
        "answer": "Studies evaluating neonatal outcomes with cryopreserved vs. fresh donor oocytes indicate that there does not appear to be a significant difference in the health of the babies. However, the number of published studies on this topic is limited.",
        "is_verified": 1
    },
    {
        "question": "What should women considering planned oocyte cryopreservation be informed about?",
        "answer": "Women considering planned oocyte cryopreservation (OC) should be fully informed of the limited published data regarding future pregnancy rates and neonatal outcomes. There is a risk of false belief that future childbearing is guaranteed, which may lead to delays in attempts at childbearing beyond the point where autologous conception is still an option.",
        "is_verified": 1
    },
    {
        "question": "What is the current understanding of pregnancy rates with cryopreserved donor oocytes?",
        "answer": "Data about pregnancy rates with cryopreserved donor oocytes seem reassuring, but larger studies are needed to confirm that live birth rates and neonatal outcomes are not compromised compared to fresh oocytes.",
        "is_verified": 1
    },
    {
        "question": "What future investigations are suggested regarding planned oocyte cryopreservation?",
        "answer": "Future investigations should provide more information about success rates and neonatal outcomes after planned oocyte cryopreservation. Larger cohorts are expected to guide women on how many oocytes to freeze to ensure reasonable reassurance of a future live birth and the optimal age for cryopreservation.",
        "is_verified": 1
    },
    {
        "question": "What factors should future studies evaluate in relation to predicting live birth rates with planned oocyte cryopreservation (OC)?",
        "answer": "Future studies should evaluate factors in addition to age, such as ovarian reserve testing or lifestyle characteristics, that can aid in predicting future live birth rates with planned OC.",
        "is_verified": 1
    },
    {
        "question": "What is recommended for women in situations with an unanticipated lack of sperm on the day of retrieval?",
        "answer": "It is recommended that oocyte cryopreservation (OC) be offered as an option for women in situations where there is an unanticipated lack of sperm the day of retrieval, or a desire to limit the number of fertilized embryos.",
        "is_verified": 1
    },
    {
        "question": "How do live birth rates per embryo transfer compare between younger and older women undergoing oocyte cryopreservation?",
        "answer": "Live birth rates per embryo transfer are improved when oocyte cryopreservation (OC) is performed in younger women as compared to older women.",
        "is_verified": 1
    },
    {
        "question": "What is the evidence regarding the optimal age for women to undergo planned oocyte cryopreservation?",
        "answer": "There are insufficient data to advise women on the optimal age to undergo planned oocyte cryopreservation (OC).",
        "is_verified": 1
    },
    {
        "question": "What does the evidence say about the impact of demographic characteristics or comorbidities on the outcome of planned oocyte cryopreservation?",
        "answer": "There is insufficient evidence to recommend that demographic characteristics or comorbidities independent of age affect the outcome of planned oocyte cryopreservation (OC).",
        "is_verified": 1
    },
    {
        "question": "What is the evidence regarding interventions to optimize outcomes after planned oocyte cryopreservation?",
        "answer": "There is insufficient evidence to recommend interventions to optimize outcomes after planned oocyte cryopreservation (OC).",
        "is_verified": 1
    },
    {
        "question": "Is ovarian reserve testing recommended to predict live birth rates after planned oocyte cryopreservation?",
        "answer": "There is insufficient evidence to recommend ovarian reserve testing to predict live birth rates after planned oocyte cryopreservation (OC) for any indication, independent of age.",
        "is_verified": 1
    },
    {
        "question": "What is the evidence regarding the number of oocytes necessary to achieve live birth after planned oocyte cryopreservation?",
        "answer": "There is insufficient evidence to counsel women of various ages on the absolute number of oocytes necessary to achieve live birth after planned oocyte cryopreservation (OC).",
        "is_verified": 1
    },
    {
        "question": "What do neonatal outcomes appear to be for infertile women using cryopreserved oocytes compared to fresh oocytes?",
        "answer": "Based on a small number of births, neonatal outcomes appear similar after using their own previously cryopreserved oocytes compared with outcomes after the use of fresh oocytes.",
        "is_verified": 1
    },
    {
        "question": "What is the strength of evidence regarding the long-term use of cryopreserved oocytes for planned oocyte cryopreservation?",
        "answer": "There is insufficient evidence to counsel patients regarding the likelihood of the long-term use of oocytes cryopreserved for planned oocyte cryopreservation (Strength of Evidence: C; Strength of Recommendation: Weak).",
        "is_verified": 1
    },
    {
        "question": "What are the recommendations for recipients regarding previously cryopreserved donor oocytes?",
        "answer": "It is recommended to tell recipients that previously cryopreserved donor oocytes are a reasonable option compared with fresh donor oocytes, as there is good evidence that there are no significant differences in per transfer pregnancy rates compared with those with fresh donor oocytes (Strength of Evidence: B; Strength of Recommendation: Moderate).",
        "is_verified": 1
    },
    {
        "question": "How does the number of donor oocytes warmed affect cumulative live birth rates?",
        "answer": "Recipients can be counseled that as the number of donor oocytes warmed increases, there is an associated increase in cumulative live birth rate (Strength of Evidence B, Strength of Recommendation: Moderate).",
        "is_verified": 1
    },
    {
        "question": "What is the relationship between live birth rates and vitriﬁed oocytes from donors with prior successful outcomes?",
        "answer": "Recipients can be counseled that live birth rates may be greater from vitriﬁed oocytes that derive from donors who had prior successful outcomes after a fresh cycle of oocyte donation (Strength of Evidence C, Strength of Recommendation: Weak).",
        "is_verified": 1
    },
    {
        "question": "Does the length of time that oocytes have been stored affect oocyte survival or pregnancy rates?",
        "answer": "Recipients can be counseled that the length of time that oocytes have been stored is not associated with differences in oocyte survival or pregnancy rates (Strength of Evidence B, Strength of Recommendation: Moderate).",
        "is_verified": 1
    },
    {
        "question": "What is the evidence regarding stimulation protocols for oocyte donors?",
        "answer": "There is insufficient evidence to recommend a particular stimulation protocol for oocyte donors or certain donor characteristics in terms of embryo quality or success rates.",
        "is_verified": 1
    },
    {
        "question": "What are the neonatal outcomes for vitriﬁed versus fresh donor oocytes?",
        "answer": "Based on limited evidence, neonatal outcomes appear similar between vitriﬁed and fresh donor oocytes.",
        "is_verified": 1
    },
    {
        "question": "What is the prediction for live birth rates after planned ovarian cryopreservation (OC)?",
        "answer": "There is insufficient evidence to predict live birth rates after planned OC.",
        "is_verified": 1
    },
    {
        "question": "How do ongoing and live birth rates compare for women undergoing planned OC at different ages?",
        "answer": "On the basis of limited data, ongoing and live birth rates appear to be higher for women who undergo planned OC at a younger vs. older ages.",
        "is_verified": 1
    },
    {
        "question": "What can ovarian reserve tests estimate?",
        "answer": "Ovarian reserve tests can be used to estimate the anticipated oocyte yield.",
        "is_verified": 1
    },
    {
        "question": "Are there differences in pregnancy rates with cryopreserved versus fresh donor oocytes?",
        "answer": "There are no significant differences in per transfer pregnancy rates with cryopreserved vs. fresh donor oocytes.",
        "is_verified": 1
    },
    {
        "question": "What do neonatal outcomes indicate with cryopreserved oocytes?",
        "answer": "Neonatal outcomes appear similar with cryopreserved oocytes.",
        "is_verified": 1
    },
    {
        "question": "What is needed regarding long-term outcomes with cryopreserved oocytes?",
        "answer": "There is a pressing need for additional data about long-term outcomes and cumulative live birth rates with cryopreserved oocytes, after planned OC and use of cryopreserved donor eggs.",
        "is_verified": 1
    },
    {
        "question": "What specialties are included in the multidisciplinary group that developed the evidence-based guideline?",
        "answer": "The multidisciplinary group includes specialists in obstetrics and gynecology, reproductive endocrinology and infertility, fertility preservation, reproductive surgery, endometriosis, uterine anomalies, fibroids, assisted reproductive technology, in vitro fertilization, and epidemiology/biostatistics.",
        "is_verified": 1
    },
    {
        "question": "Who participated in the document scoping and review for the clinical practice guideline?",
        "answer": "A select group of patients participated in the document scoping and review.",
        "is_verified": 1
    },
    {
        "question": "What types of professionals reviewed the document during the open review period?",
        "answer": "The document was reviewed by ASRM members, including patient advocates, genetic counselors, mental health professionals, nursing professionals, legal professionals, laboratory personnel, research scientists, and physicians boarded in one or more specialties.",
        "is_verified": 1
    },
    {
        "question": "What is the significance of oocyte cryopreservation in reproductive medicine?",
        "answer": "Oocyte cryopreservation is a technique used to preserve a woman's eggs for future use, which can be important for fertility preservation in cases of medical conditions, age-related fertility decline, or personal choice. It allows women to delay childbearing while maintaining the possibility of pregnancy later on.",
        "is_verified": 1
    },
    {
        "question": "What are the guidelines related to mature oocyte cryopreservation according to the American Society for Reproductive Medicine?",
        "answer": "The American Society for Reproductive Medicine has established guidelines for mature oocyte cryopreservation, emphasizing the importance of evidence-based practices and regular updates to the guidelines based on new scientific developments. These guidelines help ensure that patients receive the most current and effective treatments available.",
        "is_verified": 1
    },
    {
        "question": "What outcomes are associated with oocyte vitrification and warming for in vitro fertilization?",
        "answer": "Successful elective and medically indicated oocyte vitrification and warming have been shown to yield favorable outcomes for autologous in vitro fertilization, with predicted birth probabilities varying based on the number of cryopreserved oocytes and the age of the woman at the time of retrieval.",
        "is_verified": 1
    },
    {
        "question": "What is the purpose of the Human Oocyte Preservation Experience (HOPE) Registry?",
        "answer": "The HOPE Registry aims to evaluate different cryopreservation techniques and the source of oocytes to assess their impact on reproductive outcomes, thereby contributing to the understanding of best practices in oocyte preservation.",
        "is_verified": 1
    },
    {
        "question": "What are the findings regarding embryo development from fresh versus vitrified metaphase II oocytes?",
        "answer": "Research indicates that there are differences in embryo development outcomes when comparing fresh versus vitrified metaphase II oocytes after intracytoplasmic sperm injection (ICSI), highlighting the importance of understanding the effects of cryopreservation on reproductive success.",
        "is_verified": 1
    },
    {
        "question": "What is the significance of oocyte vitrification in assisted reproductive technology?",
        "answer": "Oocyte vitrification is a method used to preserve human oocytes (eggs) for future use in in vitro fertilization (IVF) programs. It allows for the storage of oocytes at very low temperatures, which can increase the chances of successful fertilization and pregnancy when the oocytes are thawed and used later. Studies have shown that vitrification can lead to better outcomes in terms of the number of viable embryos available for transfer, and it is particularly beneficial for women who wish to delay childbirth or who are undergoing treatments that may affect their fertility.",
        "is_verified": 1
    },
    {
        "question": "What are the risks associated with ovarian hyperstimulation syndrome (OHSS) in relation to oocyte vitrification?",
        "answer": "Ovarian hyperstimulation syndrome (OHSS) is a potential complication of fertility treatments that stimulate the ovaries to produce multiple eggs. The excerpt mentions a strategy to avoid OHSS by not using human chorionic gonadotropin (hCG) in combination with oocyte vitrification and GnRH agonist triggering. This approach aims to minimize the risk of OHSS while still allowing for effective oocyte retrieval and preservation, thereby improving patient safety during assisted reproductive cycles.",
        "is_verified": 1
    },
    {
        "question": "How does age affect the probability of live birth with oocyte cryopreservation?",
        "answer": "The excerpt references a meta-analysis that examines age-specific probabilities of live birth following oocyte cryopreservation. As women age, the quality and quantity of their oocytes decline, which can significantly impact the chances of achieving a live birth after using frozen oocytes. This analysis provides valuable insights for women considering oocyte cryopreservation, helping them understand how their age may influence their fertility outcomes.",
        "is_verified": 1
    },
    {
        "question": "What is the role of anti-Müllerian hormone (AMH) in assessing female fertility?",
        "answer": "Anti-Müllerian hormone (AMH) is a hormone produced by ovarian follicles and is used as a marker of ovarian reserve. The excerpt mentions AMH in the context of fertility, indicating its importance in evaluating a woman's reproductive potential. Higher levels of AMH are generally associated with a greater number of available eggs, while lower levels may indicate diminished ovarian reserve, which can affect fertility treatment options and outcomes.",
        "is_verified": 1
    },
    {
        "question": "What is ovarian reserve testing?",
        "answer": "Ovarian reserve testing refers to a series of assessments that evaluate the quantity and quality of a woman's remaining eggs (oocytes) in her ovaries. It is often used in fertility evaluations to determine a woman's reproductive potential and guide treatment options.",
        "is_verified": 1
    },
    {
        "question": "What are the potential clinical implications of ovarian reserve testing?",
        "answer": "The potential clinical implications of ovarian reserve testing include informing patients about their fertility status, guiding decisions regarding assisted reproductive technologies (ART), and helping to predict the likelihood of success with treatments such as in vitro fertilization (IVF).",
        "is_verified": 1
    },
    {
        "question": "What is oocyte vitrification?",
        "answer": "Oocyte vitrification is a cryopreservation technique used to freeze and store oocytes (eggs) at very low temperatures. This method allows for the preservation of oocytes for future use in fertility treatments, such as IVF, without causing damage to the eggs.",
        "is_verified": 1
    },
    {
        "question": "What are the outcomes of babies born from vitrified oocytes?",
        "answer": "Studies have shown that babies born from vitrified oocytes do not exhibit an apparent increase in congenital anomalies compared to those born from fresh oocytes, indicating that vitrification is a safe method for preserving fertility.",
        "is_verified": 1
    },
    {
        "question": "What is the significance of the study comparing fertilization and embryo development between fresh and vitrified sibling oocytes?",
        "answer": "The significance of this study lies in its potential to provide insights into the effectiveness of vitrification compared to fresh oocytes, which can influence clinical practices in fertility treatments and improve success rates in assisted reproductive technologies.",
        "is_verified": 1
    },
    {
        "question": "What does the term 'cryobank' refer to in the context of oocyte donation?",
        "answer": "A cryobank refers to a facility that stores frozen biological samples, such as oocytes, sperm, or embryos, for future use in assisted reproductive technologies. In the context of oocyte donation, cryobanked oocytes can be used to help individuals or couples conceive.",
        "is_verified": 1
    },
    {
        "question": "What are the pregnancy rates associated with the use of vitrified oocytes in egg donation programs?",
        "answer": "Research indicates that the pregnancy rates associated with the use of vitrified oocytes in egg donation programs are comparable to those achieved with fresh oocytes, suggesting that vitrification is an effective method for preserving reproductive options.",
        "is_verified": 1
    },
    {
        "question": "What are the outcomes of using cryopreserved donor oocytes compared to fresh donor oocytes?",
        "answer": "The study by Kushnir et al. (2018) provides new national outcome data on fresh versus cryopreserved donor oocytes, indicating differences in success rates and outcomes between the two methods of oocyte utilization.",
        "is_verified": 1
    },
    {
        "question": "What is the impact of double vitrification on delivery rates of embryos developed from vitrified oocytes?",
        "answer": "According to Cobo et al. (2013), the outcome of cryotransfer of embryos developed from vitrified oocytes shows that double vitrification has no impact on delivery rates, suggesting that the vitrification process itself does not adversely affect the success of embryo transfer.",
        "is_verified": 1
    },
    {
        "question": "What cumulative outcomes were reported from six years of ovum donation using vitrified oocytes?",
        "answer": "Cobo et al. (2015) reported on six years of experience in ovum donation using vitrified oocytes, detailing cumulative outcomes, the impact of storage time on oocyte viability, and the development of a predictive model for oocyte survival rate, which is crucial for optimizing fertility treatments.",
        "is_verified": 1
    },
    {
        "question": "What are the lessons learned from the comparison of freeze-all, oocyte vitrification, and fresh embryo transfer?",
        "answer": "Braga et al. (2016) discuss the lessons learned from an egg-sharing donation program comparing freeze-all strategies, oocyte vitrification, and fresh embryo transfer, providing insights into the effectiveness of these approaches in assisted reproductive technology.",
        "is_verified": 1
    },
    {
        "question": "¿Qué es la criopreservación de ovocitos?",
        "answer": "La criopreservación de ovocitos es un proceso que permite congelar y almacenar ovocitos (óvulos) para su uso posterior en tratamientos de fertilidad, como la fecundación in vitro.",
        "is_verified": 1
    },
    {
        "question": "¿Cuáles son los objetivos de la guía sobre criopreservación de ovocitos?",
        "answer": "El objetivo de la guía es proporcionar recomendaciones basadas en la evidencia sobre la eficacia de la criopreservación de ovocitos para la fecundación in vitro, tanto de ovocitos de donantes como de ovocitos planificados.",
        "is_verified": 1
    },
    {
        "question": "¿Qué tipo de estudios se incluyeron en la búsqueda bibliográfica realizada por la Sociedad Estadounidense de Medicina Reproductiva?",
        "answer": "La búsqueda incluyó revisiones sistemáticas, metaanálisis, ensayos controlados aleatorios y estudios observacionales comparativos prospectivos y retrospectivos publicados entre 1986 y 2018.",
        "is_verified": 1
    },
    {
        "question": "¿Cuáles son las principales medidas de resultado en la investigación sobre criopreservación de ovocitos?",
        "answer": "Las principales medidas de resultado incluyen la tasa de nacidos vivos, la tasa de embarazo clínico, los resultados obstétricos y neonatales, y los factores que predicen los resultados reproductivos.",
        "is_verified": 1
    },
    {
        "question": "¿Qué recomendaciones se desarrollaron en la guía sobre criopreservación de ovocitos?",
        "answer": "Se desarrollaron recomendaciones para predecir la probabilidad de nacidos vivos después de la criopreservación planificada, la criopreservación autóloga en mujeres infértiles y la criopreservación de donantes, así como sobre los resultados neonatales al usar ovocitos frescos versus criopreservados.",
        "is_verified": 1
    },
    {
        "question": "¿Cuál es la conclusión sobre la evidencia de las tasas de nacidos vivos después de la criopreservación planificada?",
        "answer": "La conclusión es que no hay evidencia suficiente para predecir las tasas de nacidos vivos después de la criopreservación planificada.",
        "is_verified": 1
    },
    {
        "question": "What are the findings regarding live birth rates for women undergoing planned AO at younger versus older ages?",
        "answer": "The excerpt indicates that live birth rates appear to improve for women who undergo a planned AO (assisted oocyte) at a younger age compared to those who do so at an older age.",
        "is_verified": 1
    },
    {
        "question": "Is there a significant difference in pregnancy rates when using cryopreserved versus fresh donor oocytes?",
        "answer": "According to the excerpt, there are no significant differences in pregnancy rates by transfer when using cryopreserved versus fresh donor oocytes.",
        "is_verified": 1
    },
    {
        "question": "What does the excerpt say about the live birth rates with vitrified versus fresh donor oocytes?",
        "answer": "The excerpt states that there is insufficient evidence to conclude that the live birth rates are the same with vitrified versus fresh donor oocytes.",
        "is_verified": 1
    },
    {
        "question": "How do neonatal outcomes compare between cryopreserved and fresh oocytes?",
        "answer": "The neonatal outcomes appear to be similar when comparing cryopreserved oocytes to fresh oocytes, according to the excerpt.",
        "is_verified": 1
    },
    {
        "question": "What is suggested for future research based on the findings in the excerpt?",
        "answer": "The excerpt suggests that future studies are needed to compare the accumulated live birth rates.",
        "is_verified": 1
    }
]